A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Status:
Recruiting
Trial end date:
2024-02-28
Target enrollment:
Participant gender:
Summary
This is a study to evaluate the efficacy and safety of TQ-B3525 in subjects with
relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.